Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
Pfizer and BioNTech have asked U.S. regulators to approve emergency use of their Covid-19 vaccine for children ages 5 to 11. The move comes at a time when children are heading back to school and ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
The federal Centers for Disease Control and Prevention has added the Covid-19 vaccine to the recommended immunization schedule for children and adolescents. The Advisory Committee on Immunization ...
The company will submit an Emergency Use Authorization request soon. Data shows the Pfizer and BioNTech COVID-19 vaccine is safe and effective for children ages 5 to 11, the companies announced ...
“This decision comes at a time when Covid-19 cases are once again climbing,” Bourla said The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus and some of the Omicron subvariants that were circulating around ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA authorized new versions of Pfizer and Moderna’s Covid-19 vaccines. WASHINGTON (CN) — ...
(Reuters) -The U.S. health regulator on Monday proposed the use of one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it ...